Cleared Special

K161856 - StatStrip Xpress Glucose Hospital Meter...

K161856 is the FDA 510(k) clearance for StatStrip Xpress Glucose Hospital Meter... by Nova Biomedical Corporation. It is a Class 2 Chemistry device (product code PZI) cleared through the Special 510(k) pathway after a 132-day FDA review.

K161856 · Nova Biomedical Corporation · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2016
Decision
132d
Days
Class 2
Risk

K161856 is an FDA 510(k) clearance for the StatStrip Xpress Glucose Hospital Meter System. Classified as Prescription Use Blood Glucose Meter For Near-patient Testing (product code PZI), Class II - Special Controls.

Submitted by Nova Biomedical Corporation (Walham, US). The FDA issued a Cleared decision on November 15, 2016 after a review of 132 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Nova Biomedical Corporation devices

Submission Details

510(k) Number K161856 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 06, 2016
Decision Date November 15, 2016
Days to Decision 132 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
44d slower than avg
Panel avg: 88d · This submission: 132d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code PZI Prescription Use Blood Glucose Meter For Near-patient Testing
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
Definition Intended For Use In Near-patient Testing Settings For In Vitro Diagnostic, Multiple-patient Use For The Quantitative Determination Of Glucose Throughout All Hospital And All Professional Healthcare Settings For Use In Determining Dysglycemia.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - PZI Prescription Use Blood Glucose Meter For Near-patient Testing

All 13
Devices cleared under the same product code (PZI) and FDA review panel - the closest regulatory comparables to K161856.
StatStrip Xpress Glucose Hospital Meter System
K182552 · Nova Biomedical Corporation · Dec 2018
StatStrip Glucose Hospital Meter System
K181043 · Nova Biomedical Corporation · Jul 2018
StatStrip Xpress 2 Glucose Hospital Meter System
K163490 · Nova Biomedical Corporation · Jan 2017
StatStrip Xpress 2 Glucose Hospital Meter System
K152986 · Nova Biomedical Corporation · Jan 2016
StatStrip Xpress Glucose Hospital Meter System
K150461 · Nova Biomedical Corporation · May 2015
StatStrip Glucose Hospital Meter
K150281 · Nova Biomedical Corporation · May 2015